We have developed "protein-and cell-based screen methods" for the isolation of new natural products. By using VDR (vitamin D receptor) immobilized magnetic beads, two new natural products were isolated rapidly. To find inhibitors of Hes1 protein, which is one of the important transcriptional factors in neural stem cells, a Hes1 dimer plate assay was developed, and then first Hes1 dimer inhibitors were found from our natural products library. As a "cell-based screen method," a reporter gene assay for screening Hh (hedgehog) signaling inhibitors was constructed. New Hh signaling inhibitors were isolated from our natural extracts library. We evaluated their Hh inhibitory activity in Hh related protein synthesis and cytotoxicity against cancers, in which Hh signaling is aberrantly activated. In addition to the naturally made compounds library (extracts library), "small molecules based on natural products" were synthesized. The total synthesis of Melleumin A, B, which were isolated by our group, was achieved. From their synthetic derivatives, inhibitors of the Wnt signal, which has been reported to cause colon cancers, were discovered. Moreover, flavanone and chromone were selected as natural product scaffolds. Many flavonoids and chromones with diverse heterocyclic units were constructed using our efficient synthetic method.
Introduction
Isolation and identification of novel naturally occurring bioactive products has played an important role in drug discovery. Because most new drugs are related to natural products or related compounds, 1) discovery of the active compounds based on natural products would be a powerful way to approach to human diseases.
We have developed a "protein-based screen method" for the quick isolation of new natural products. Targeting of drugs to specific "proteins," for the treatment of specific diseases, is also of great clinical importance. On the other hand, isolation by the guided biological activity of a "cell-based screen method" is also an attractive method for obtaining desired phenotypes by small molecules. A reporter gene assay using cells has been constructed allowing the isolation of new hedgehog (Hh) signaling inhibitors, which is an aberrant signal in several type of cancers.
Synthesis of small molecules based on their scaffolds would be of chemical relevance to living cells and organs, protein binding, absorption, distribution, metabolism, and excretion. 2, 3) We are interested in making "synthetic small molecules based on natural products." Small molecules which have a scaffold of natural products would have a big chance to be candidates as new drugs. To create such bioactive molecules, we focused on the new natural products, Melleumin A, B, which were isolated by our group. Flavonoids which were known to have broad bioactivity were also used as a template.
This review describes our recent efforts in approaches to cancer cells and neural stem cells, by the above three core: "protein based screen," "cell based screen," and "naturally made or synthetic compounds library." (Fig. 1) 4) There is a strong demand for the "quick" discovery of novel natural products which are potential candidates for new medicines. To this end, we developed a method for the rapid discovery of natural products using protein magnetic beads. By using a combination of protein immobilized beads, followed by HPLC analysis, the time required to isolate of target compounds can be greatly shortened. Magnetic nanoparticles have been widely utilized in a range of fields including biology, chemistry, and molecular imaging. 5) Immobilization of proteins on magnetic beads has facilitated protein purification, 6) the detection of protein-protein interactions, 7) cancercell detection (using immobilized antibody), 8) and isolation of the target protein of small molecules. 9) Handa et al. have described a method for the separation of FK506 from extracts by using FKBP (FK506 binding protein) immobilized magnetic beads. 10) Magnetic beads are particularly useful for the immobilization of proteins, as bead-bound compounds can be easily separated from other soluble components by using a magnet, thereby lending themselves to high-throughput system (HTS) applications. Compared with the many centrifuge steps that would be required for separation if sepharose beads were used, the simple collection of magnetic beads on the wall of the tube by use of a magnet, followed by removal of the supernatant, is a much easier and far less time-consuming method ( Fig. 2 ). To establish a method for the isolation of naturally occurring small molecules from the complex mixtures composed of extracts of natural resources (such as plants, marine organisms, actinomycetes, mold and myxomycetes), we first selected human vitamin D receptor (hVDR), a member of the superfamily of nuclear receptors, as the target protein. This receptor and its ligands have been well studied. It is known that 1a,25-dihydroxyvitamin D 3 [1a,25(OH) 2 VD 3 ] (compound 1) is an endogenous cellular ligand of hVDR, and that vitamin D 3 (VD 3 ) (compound 2), which is the precursor of compound 1, also binds but with much lower affinity than compound 1.
Protein-Based Approaches 1.A Method for the Rapid Discovery of Naturally Occurring Products Using Proteins Immobilized on Magnetic Beads and Reverse Affinity Chromatography
hVDR, which was prepared from Escherichia coli, was immobilized on COOH-coated magnetic beads (Dynabeads M-270 carboxylic acid, Invitrogen, Norway) that had been treated with N-hydroxy succinimide and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) ( Fig.  2D) . A suspension of hVDR-or glutathione S-transferase (GST)-bound magnetic beads and ligand 1 was gently mixed at 4°C for 2 h ( Fig. 2A ), after which excess ligand solution was easily removed after the beads were gathered on the wall of the tube using a magnet (Fig. 2B ). The HPLC profile of the eluted EtOH solution is shown in Fig. 3A , and compound 1 bound to hVDR can be clearly detected. Compound 1 binding to negative control GST-bound magnetic beads was similarly examined, and showed a very small peak for 1 ( Fig.  3C ). When binding of the weak compound 2 was assayed, the peak of 2 bound to hVDR was very small, as shown in Fig.  3B , and was similar to the peak obtained following incubation with control GST magnetic beads ( Fig. 3D ).
Based on this result, we then screened several plant extracts, and determined that an extract of Limocharis flava (the aerial part) yielded HPLC peaks following binding to and elution from hVDR beads. We therefore proceeded to purify and identify "peak" as follows. The methanol extract of L. flava (2.2 g) was partitioned between H 2 O, and nhexane and ethyl acetate. Further purification by consecutive steps of silica gel column chromatography and reversed-Midori A. Arai, born in 1972 (2001) (2002) . Special postdoctoral researcher at RIKEN (2003 RIKEN ( -2004 , Assistant Prof. Teikyo University (2004) (2005) (2006) , then Associate Prof. Chiba University (2006-present) . She received the Sankyo Award in Synthetic Organic Chemistry, Japan, 2001, the poster award at the 22nd Naito Conference, Japan, 2008, and the Pharmaceutical Society of Japan Award for Young Scientists in 2010. Her current research interests include chemical biology, natural products chemistry, and combinatorial chemistry. phase HPLC yielded two new labdane type diterpenes (compounds 3 and 4) ( Fig. 4 ). Assay of the binding of the isolated pure compounds to hVDR beads revealed stronger binding of compound 4 than compound 3.
A method of screening for naturally occurring products that bind to a specific target protein that is immobilized on magnetic beads was established. This method was proven to be applicable to the identification of new natural products, which interact with a specific protein immobilized on the beads, from an extract of a natural resource. This method has the further advantages that it can identify the HPLC peak corresponding to the target compound for isolation, as well as provide important UV, circular dichroism (CD) or MS profile information. 11) The second example of a "protein-based screen" is the Hes1 dimer plate screen. Recent studies have revealed that the adult mammalian brain has some capacity for neuronal regeneration after insult. [12] [13] [14] Therefore, neural stem cells (NSCs) are of great clinical interest regarding the treatment of neural diseases. Basic-helix-loop-helix (bHLH) repressor and activator genes play an essential role in embryogenesis, neurogenesis and the development of many organs. 15, 16) bHLH activators, such as Mash1 and E47, control the differentiation of NSCs into neurons by the activation of neural-specific gene expression. Hes factors (Hes1, Hes3 and Hes5) regulate cell proliferation and differentiation in the nervous system, acting as bHLH repressors by either active or passive suppression of bHLH activator activity. Active suppression comprises Hes binding to N box (CACNAG) as homodimers to suppress bHLH activator transcription ( Fig.  5 ). We hypothesized that the inhibition of Hes1 dimer formation would result in the acceleration of bHLH activator transcription, which may generate the differentiation of NSCs into neurons. Small molecules that can modulate the activity of Hes1 would be candidates for a medicine to treat neural disease, especially as 'regenerative medicine' for new neurons. As the precise mechanisms of NSC proliferation and differentiation contain many unknown factors, small molecules that control the roles of bHLH factors are potentially important chemical tools.
Inhibitors of Hes1 Dimer Formation from Natural Products
We developed a rapid in vitro HTS for identifying Hes1 inhibitors using fluorophore-labeled Hes1 and Hes1 immobilized on microplates ( Fig. 6 ). In the presence of an inhibitor compound, the level of Hes1 dimerization was reduced, as detected by a corresponding reduction in fluorescence. Using this system, we identified the first Hes1 dimer inhibitors from our natural products library. Hes1 protein was immobilized on a microplate by chemical linkage. To form the homodimer of Hes1, Cy3-dye-labeled Hes1 was added to the Hes1-immobilized well. After 1 h incubation at room temperature, the well was washed and the fluorescence was measured by a microplate reader. The dimer complex between Hes1 and Cy3-Hes1 was detected successfully. We reported previously on the development of a HTS of vitamin D receptor-co-activator interaction using vitamin D derivatives. 17) In the study, we found the HCHO-fixation method was effective in detecting protein-protein interaction. Although the fluorescence intensity of the Hes1 dimer complex was greatly improved with HCHO-fixation, the risk of structural modification of some natural compounds, especially quinone and hydroquinone type compounds, was observed. Therefore we did not use the HCHO-fixation method in the present study. The compounds of our natural product library were evaluated using this constructed HTS system. This library consists of natural compounds isolated by our research group, including terpenoids, flavonoids, phenylpropanoids, their glycosides and bisindole alkaloids. We identified six natural compounds as inhibitors of Hes1 dimer formation ( Fig. 7 ) with the following IC 50 values: lindbladione (5), 18, 19) IC 50 , 4.1 mM isolated from the myxomycetes Lindbladia tubulina; two bisindole alkaloids, lycogarubin B (6), 20) 16.5 mM and lycogaric acid A (7), 21) 6.0 mM isolated from the myxomycetes Lycogala epidendrum; demethyl-2Љ-epifraxamoside (8), 22) 7.8 mM isolated from Jasminum grandiflorum; and, two lignan glycosids, lyoniside (9), 23) 48.1 mM and nudiposide (10), 24) 9.6 mM isolated from Saraca asoca. Compounds 5 to 7 are natural products isolated by the Ishibashi group from myxomycetes (true slime molds), which are an unusual group of primitive organisms that can be assigned to one of the lowest classes of eukaryotes. We subsequently examined the intracellular inhibition activity of these compounds. Hes1 dimer binds to N box sequences in the target promoter of bHLH activators, thus suppressing their transcription. A cell-based reporter assay for measuring the effect on Hes1-induced repression 25) was performed. Of the inhibitors identified by protein-based screening, 5 and 7 showed dose-dependent inhibition of the Hes1mediated suppression of gene expression. With compounds 5 and 7, transcription recovered to around 60% at 50 mM.
Cell-Based Approaches
To discover the inhibitors of signaling in cancer cells or neural stem cells, we have been trying to create cell based assays, which use a stable cell line with a target gene. For neural stem cells, the promoters of bHLH factor were used to find the modulators of bHLH factors expression. For cancer cells, the aberrant signaling was targeted. In this review, we would like to describe the development of a cell-based assay for Hh signaling inhibitors.
Discovery of Hh Signaling Inhibitors from Natural Products
The hedgehog (Hh)/GLI signaling pathway has recently been implicated in several tumors, 26, 27) such as those in the skin, brain, prostate, digestive tract, pancreas, and lung. The vertebrate Hh family includes three members: sonic Hh (Shh), desert Hh, and indiana Hh, which all bind to the same receptor, Patched (PTCH). In the absence of a Hh ligand, PTCH interacts with Smoothend (Smo) to inhibit its function, preventing the activation of the downstream signaling cascade. Upon Hh binding, Smo inhibition is released, resulting in the activation of the downstream signaling cascade through the release of the transcriptional factor GLI from a macromolecular complex on microtubules ( Fig. 8 ). In some types of human tumors, Hh/GLI signaling is constitutively activated because of mutations in PTCH or SMO, leading to tumor formation and progression. Thus, targeted Hh/GLI signaling is anticipated as an effective cancer therapeutic strategy. 28) Cyclopamine has been identified as an inhibitor of Hh signaling by binding to SMO, 29, 30) and other types of SMO antagonists have been reported, such as Cur-61414 31) and SANTs. 32) In addition, several small-molecule inhibitors of Hh signaling, including GLI-mediated transcription in-hibitors (GANTs), 33) inhibitor of class IV alcohol dehydrogenase (JK184) 34) and a small molecule that binds Shh protein (robotnikinin), 35) have been reported, but there is still an urgent need to identify different types of GLI-mediated transcriptional inhibitors.
To discover inhibitors of the Hh/GLI signaling pathway from natural resources, we have recently reported the construction of a cell-based screening assay system for the Hh/GLI signaling pathway ( Fig. 9 ). 36) This is an assay using a GLI-dependent luciferase reporter in human keratinocyte cells (HaCaT) expressing GLI1 under tetracycline control (T-REx system). The 12 consecutive GLI-binding sites (12ϫ GACCACCCA) and the TK promoter were inserted into pGL4.20 plasmid (Promega, U.S.A.). The constructed plasmid, pGL4-GLI BS, was stably transfected into HaCaT cells expressing exogenous GLI1 protein under tetracycline control. During the screening of our isolated natural products library and natural resource libraries, including plant extracts and actinomycete extracts with the assay system, we identified some natural products and natural plant extracts as GLI1-mediated transcriptional inhibitor samples.
From our natural products library including terpenoids, flavonoids, phenylpropanoids, their glycosides and bisindole alkaloids, sesquiterpene zerumbone (11; IC 50 7.1 mM) and several bisindole alkaloids including staurosporinone (12; IC 50 1.8 mM) were identified as Hh signaling inhibitors (Fig.  10 ). From the natural plant extracts which exhibited GLI1mediated transcriptional inhibitory activities, natural products were isolated as Hh signaling inhibitors. The methanol extract of Physalis minima (2.7 g) was partitioned between H 2 O, and n-hexane and ethyl acetate. Cells treated with 10 mg/ml of the n-hexane and ethyl acetate fractions showed 51% and 20% reporter activity, respectively, and Ͼ95% cell viability. Because TLC analysis of the n-hexane and ethyl acetate-soluble fractions revealed the presence of nearly the same compounds, we combined and further purified them by consecutive steps of silica gel column chromatography, sephadex LH-20 column chromatography, and reversedphase HPLC. This gave two compounds, which were identified as physalin F (13), 37) and physalin B (14), 38) by comparison of their spectral data with reported values. Physalins F (13) and B (14) dose-dependently inhibited GLI1-mediated transcriptional activity with little or no effect on cell viability. The IC 50 values of these two compounds in this assay were 0.66 mM and 0.62 mM, respectively. In addition, it should be emphasized that the compounds did not reduce the viability of normal HaCaT human keratinocytes near their IC 50 concentrations. PANC1, a human pancreatic cancer cell line, expresses numerous Hh/GLI signaling pathway components, including Shh, PTCH, suppressor of fused, GLI1, and GLI2, indicating that the Hh/GLI signaling pathway is activated in PANC1 cells. We confirmed the effect of compounds (11) (12) (13) (14) on the expression of Hh/GLI signaling components in PANC1 cells by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis (Fig. 11A) . These compounds decreased the mRNA expression of Gli1, Gli2, and Ptch genes. These results indicate that these compounds inhibit the expression of these components at the transcriptional level. We further examined the effect of 13 and 14 on the protein expression of PTCH in PANC1 cells (Fig. 11B) . These inhibitors apparently decrease the PTCH expression in PANC1 cells at 4 mg/ml. We investigated the effects of isolated Hh inhibitors on the viability of PANC1 cells using a fluorimetric microculture cytotoxicity assay (FMCA). Compounds 11, 12, 13 and 14 were cytotoxic to PANC1 cells with IC 50 values of 40, 68, 2.6, and 5.3 mM, respectively.
Our continuous study also led to the isolation of several potent Hh inhibitors from natural resources. Bioassay-guided fractionation of Zizyphus cambodiana extract led to the isolation of three active pentacyclic triterpenes, including colubrinic acid (15) . 39) Potent inhibitors were isolated from Acacia pennata, 40) Adenium obesum 41) and Excoecaria agallocha. 42 We recently found a new type of Hh inhibitor from Excoecaria agallocha. 42) A new flavonoid glycoside 20 inhibits Hh signaling by arresting the translocation of GLI into the nucleus of PANC1. Moreover, it was revealed that this inhibition was not affected by SMO. Even in the SMO knocked down C3H10T1/2 cells, 20 inhibited PTCH mRNA expression, which is regulated by the Hh signaling pathway. Most known Hh inhibitors, including cyclopamine, repress the pathway by antagonizing SMO activation; however, one of the oncogenic SMO mutants is apparently resistant to cyclopamine, and most SMO inhibitors were not effective against medullablastoma and cancer associated with downstream lesions. Therefore, a new mechanism of Hh inhibition, other than SMO inhibitors, is very important for clinical use. 43) A novel peptide lactone, melleumin A (21) , and its seco acid methy ester, melleumin B (22) were discovered by the Ishibashi group in 2005 from cultured plasmodium of the myxomycete Physarum melleum (Fig. 12 ). 44) The stereo- chemistry of 21 and 22 at the chiral centers was established to be 3S, 10S, and 11R-configurations. Because the quantity of isolated 21 and 22 was very small, we decided to synthesize those compounds to evaluate their biological activity. The absolute stereochemistry of the C-4 position was determined to be S by total synthesis of melleumin B (22) . 45) The 10R-epimer (23), 3R-epimer (24) and (3R,10R)-epimer (25) of 22 showed moderate Wnt signal inhibitory activity. 45, 46) Wnt signaling exhibits aberrant activation in many cancer cells, especially in colon cancers. 47) The aberrant activation of this signal is caused by the mutation or loss of function in b-catenin, T-cell factor/lymphoid enhancer factor (TCF/ LEF), and glycogen synthase kinase 3b (GSK3b) and other things. Small molecules that act on certain molecular components in the Wnt signal pathway would be potential candidates for treating cancer. Several Wnt signal inhibitors have been previously reported. However, there are not many effective Wnt signal inhibitors. We have also reported natural products or their derivatives that act as Wnt signal inhibitors, such as bisindole alkaloid cis-dihydroarcyriarubin C, 48) and the new natural products eleutherinoside B-E. 49) Luo et al. reported the first total synthesis of 21, 4Repimer and other derivatives by intramolecular lactamization at the N5-C6 amide bond, 50) and found moderate Wnt inhibition in 4-epi-melleumin B and 4-epi-deoxymelleumin A. We also succeeded in the total synthesis of melleumin A (21) and its 3R-epimer (26) . In order to analyze Wnt inhibitory activities on cyclic compounds related to 21, melleumin Alike compounds that do not contain a lactone subunit that is easily cleaved in cells were designed and synthesized. These compounds showed moderate Wnt inhibitory activity.
Synthesis and Evaluation of Small Molecules Based on Natural Products 3.1. Total Synthesis and Evaluation of Wnt Signal Inhibition of Melleumin A, B and Their Derivatives
Melleumin A (21) and B (22) consist of four residues: p-methoxybenzoic acid (pMBz), L-threonine (L-Thr), glycine (Gly), and an unusual amino acid, a tyrosine-attached acetic acid (TyrA). Because compound 22 is a seco acid methyl ester of 21, we attempted the intramolecular lactone formation of the seco acid of 22 that was obtained by hydrolysis of synthesized 22. However, several conditions prevented cyclization. Therefore, we changed strategies to synthesize 21 by N8-C9 amide bond formation as a cyclization step (Chart 1). Compound 27 could be prepared from dipeptide 28 (TyrA-Gly unit) and N-p-methoxybenzoyl-L-threonine 32 (pMBz-L-Thr unit). Dipeptide 28 could be obtained from (3S,4S)-b-hydroxy ester 29 and Boc-glycine (30) .
To obtain (3S,4S)-TyrA unit 29 stereoselectively, the reduction of b-ketoester was carried out. Desired (3S,4S)-b-hydroxy ester 29 was obtained in 69% yield with a ratio of 29/34 (3R,4S)ϭ93/7, with K-selectride. When NaBH 4 was used, (3R,4S)-TyrA unit 34 was predominately obtained as expected, which was used for the synthesis of 3-epi-melleumin A (26) .
After deprotection of the Boc group, coupling with N-Bocglycine gave 35 in good yield (Chart 2). Compound 35 was hydrolyzed by lithium hydroxide to give a desired carboxylic acid that was used in the next step without further purification. Compound 32 (pMBz-L-Thr unit) and p-methoxybenzoyl chloride, and the aforementioned carboxylic acid, were coupled using dicyclohexylcarbodiimide (DCC) to give com- pound 37 in 50% yield in 2 steps. The Boc group and tertbutyl ester of 37 were deprotected to give compound 27. Macrolactamization of 27 was investigated for various coupling reagents. Pentafluorophenyl diphenylphosphinate (FDPP) and O-(7-azabenzotriazol-l-yl)-N,N,N Ј,N Ј-tetramethyluronium hexafluorophosphate (HATU) provided 39 in 28% and 24% yield (2 steps), respectively. The benzyl group was finally removed by hydrogenolysis to give melleumin A (21) . The 1 H-and 13 C-NMR spectral data of the synthetic material were identical to those of the natural product. 1) The optical rotation of synthetic melleumin A (21) showed the same sense as the natural product {[a] D 18 ϩ16 (cϭ0.97, MeOH); [a] D 18 ϩ27 (cϭ0.15, MeOH) lit. 44) }. X-Ray crystallographic analysis of synthetic melleumin A (21) succeded. This result strongly confirmed the absolute structure of melleumin A (21) . Starting from (3R,4S)-b-hydroxy ester 34, 3-epimelleumin A (26) was also synthesized as shown in Chart 2.
Next, we examined the biological activity of melleumin A (21) and 3-epi-melleumin A (26) . Unfortunately, melleumin A (21) had weak Wnt signal inhibitory activity and 3-epimelleumin A (26) had no inhibitory activity. However, we had previously explored and found that melleumin B derivatives became Wnt signal inhibitors. Therefore, we thought it possible to add Wnt inhibition to melleumin A-like compounds. We designed melleumin A-like compounds as shown in Fig. 13 . Although the target molecule of active melleumins is unknown at this stage, most melleumins show moderate or weak Wnt inhibition. Therefore, we hypothesized that two amides in the ring and aryl groups could be important as a common structure, same moieties as melleumin A. Because melleumin B derivatives, which are open chain analogues of melleumin A, have moderate Wnt inhibitory activity, greater flexibility would be important to fit the target molecule (larger ring). The lactone moiety was removed for compound stability in the cells. At this time, a 13-membered ring was chosen instead of the 12-membered ring of melleumin A. By using a ring-closing metathesis (RCM) reaction as a key step, we synthesized three melleumin-like compounds (41-43) ( Fig. 14) .
Next we examined the Wnt signal inhibitory activity of the synthesized compounds using a luciferase reporter gene assay. Wnt signaling activates gene transcription by forming a complex between b-catenin and TCF/LEF, a DNA-binding protein. Super TOP-Flash, a reporter plasmid with multiple TCF-binding sites (CCTTTGATC), was stably transfected into 293 cells. Super FOP-Flash has eight mutated TCFbinding sites (CCTTTGGCC); therefore, a selective inhibitor would not affect transcription in Super FOP-Flash-transfected cells. Figure 15 shows the comparison of the Wnt signal inhibitory activities of melleumin A, B, their derivatives and melleumin A-like compounds (50 mM). Natural products, melleumin A (21) and melleumin B (22) , reduced Wnt transcriptional activity to 74% and 64%, respectively. Of them, 10-epi-melleumin B (23) seemed to be the most active (46%). Regarding cyclic-peptide type (melleumin A type) compounds, 3-epi-melleumin A (26) lost activity; however, melleumin A-like compound (41) showed 20% more inhibition (54%) compared with 21 (74%).
To evaluate the structural differences between melleumin A (21) and melleumin A-like compounds, density functional theory (DFT) calculation of 41, the most active of the three melleumin A-like compounds, was carried out (Fig. 16 ). The DFT calculation at the level of B3LYP/6-31G* suggested a slight difference in the three-dimensional orientation of two amide units in the ring. The two amide torsion angle (f) was changed to 86.7°(41) from 112.4° (21) . The distances of N1-N2 and N1-N3 were changed to 3.35 Å (41) from 2.93 Å (21), and 3.64 Å (41) from 3.71 Å (21), respectively. Since two amides in the ring and aryl groups are common structures in bioactive melleumins, the Wnt inhibition of 41 might be due to this conformational change in the structure.
The total synthesis of melleumin A (21), melleumin B (22) , and their derivatives were achieved. Moreover, we designed and synthesized melleumin A-like compounds to seek a possible Wnt signaling inhibitor. We succeeded to add Wnt inhibitory activity to a melleumin A-like compound, though natural product 21 showed weak activity. Since few small molecules are known to be Wnt signal inhibitors, and their clinical use has received great attention, we believe that peptide-based inhibitors will be worth synthesizing to evaluate their potential. 51) To find new bioactive small molecules based on natural products, an efficient synthesis method in which it is easy to add molecules with structural and/or substitution diversity is important. We focused on chromones and flavonoids, which are important bioactive compounds isolated from a wide range of plants. Many studies have suggested that flavonoids have biological activity, such as antiviral action, anti-inflammatory effects, and a beneficial influence on multiple cancer-related biological pathways. We envisioned that heterocyclic-substituted chromones or flavonoids would act as new bioactive compounds. Efficient one-pot syntheses methods of flavones with disubstituents at the 2 and 3 positions have yet to be developed. Chawla et al. reported the first one-pot synthesis of 3-arylideneflavonoids from 2Ј-hydroxyacetophenones with aromatic aldehydes in aq. NaOH. 52) Dhara et al. reported an improved one-pot synthesis of 3-arylideneflavonoids and 2,3disubstituted chromanones by using furfural or thiophen-2aldehyde. 53) The Baker-Venkataraman rearrangement is another important one-pot method for synthesizing 3-acyl flavonoids from 2Ј-hydroxyacetophenones, and a 3-acyl flavonoid with pyridine units was synthesized in this manner. 54) To construct small molecules with complexity and diversity to increase the number of protein-binding elements, we developed efficient one-pot syntheses methods of 2,3-disubstituted chromones and 3-substituted flavonoids (Chart 3). After the construction of corresponding chalcone from hydroxyacetophenone derivatives 44 and heterocyclic aldehyde 45 or aromatic aldehyde 46, a tandem type Michael-Aldol reaction gave the 2,3-heterocyclic disubstituted chromones 47 or 3-heterocyclic substituted flavonoids 48.
Efficient Synthesis of Chromone and Flavonoid Derivatives with Diverse Heterocyclic Units
One-pot synthesis by Michael-Aldol reaction of chromone derivatives bearing pyridine units was optimized by using 4Јbenzyloxy-2Ј-hydroxyacetophenone 49. The reaction proceeded smoothly with pyridinecarboxaldehyde 50a-h ( Table 1 , entries 1-8). Endo olefinic products 51 were obtained in good yield in all cases apart from 50e. In some cases, exo products were obtained when the reactions were quenched in a shorter reaction time. The position of CHO or Br on the pyridine did not affect the yield. Furfurals 50i and 50j (entrys 9-10), thiophen-2-aldehydes 50k and 50l (entrys 11-12) also gave the desired product. Because the cyclization of chalcones which was made from aromatic aldehyds 46 (Aldehyde A) were very slow, 3-heterocyclicsubstituted flavonoids 48 were also obtained in one-pot reaction (Chart 3). Variety of 3-heterocyclic-substituted flavonoids were synthesized. 51) Next, application of this efficient reaction to solidphase reactions to construct small molecule libraries was examined. After attaching the acetophenone derivative to (4methoxyphenyl) diisopropyl-silylpropyl polystyrene beads (novabiochem), a desired reaction smoothly proceeded to give 2,3-heterocyclic-substituted chromones (see ref. 51 ). In the case of 3-heterocyclic-substituted flavonoids, after optimization of the condition, the desired product 54b was obtained in 82% (Chart 4). Furthermore, to add diverse substituents on the molecules, we examined Suzuki-Miyaura coupling on a pyridine unit on solid phase. Under several reported conditions, the described combination gave coupling products in good yield. p-Acetamidopheny-(55b) attached compound was obtained in 81% (endo only).
Recently, we succeded in constructing a library of chromones and flavonoids with heterocycles. By the screening of this library, several compounds were found to be Hes1 promoter inhibitors. The application of these inhibitors to neural stem cells is in progress.
